AAAAAA
Results:
1-11
|
Results: 11
Authors:
ZIMMERLI W
WIDMER AF
BLATTER M
FREI R
OCHSNER PE
Citation: W. Zimmerli et al., ROLE OF RIFAMPIN FOR TREATMENT OF ORTHOPEDIC IMPLANT-RELATED STAPHYLOCOCCAL INFECTIONS - A RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 279(19), 1998, pp. 1537-1541
Authors:
HALSEY NA
BLATTER M
BADER G
THOMS ML
WILLINGHAM FF
ODONOVAN JC
PAKULA L
BERUT F
REISINGER KS
MESCHIEVITZ C
Citation: Na. Halsey et al., INACTIVATED POLIOVIRUS VACCINE ALONE OR SEQUENTIAL INACTIVATED AND ORAL POLIOVIRUS VACCINE IN 2, 4 AND 6-MONTH-OLD INFANTS WITH COMBINATIONHAEMOPHILUS-INFLUENZAE TYPE-B HEPATITIS-B VACCINE, The Pediatric infectious disease journal, 16(7), 1997, pp. 675-679
Authors:
BLATTER M
BURKHALTER R
HASENFRATZ P
NIEDERMAYER F
Citation: M. Blatter et al., INSTANTONS AND THE FIXED-POINT TOPOLOGICAL CHARGE IN THE 2-DIMENSIONAL O(3) SIGMA-MODEL, Physical review. D. Particles and fields, 53(2), 1996, pp. 923-932
Authors:
BLATTER M
NIEDERMAYER F
Citation: M. Blatter et F. Niedermayer, NEW FIXED-POINT ACTION FOR SU(3) LATTICE GAUGE-THEORY, Nuclear physics. B, 482(1-2), 1996, pp. 286-302
Authors:
BLATTER M
BURKHALTER R
HASENFRATZ P
NIEDERMAYER F
Citation: M. Blatter et al., PERFECT TOPOLOGICAL CHARGE FOR ASYMPTOTICALLY FREE THEORIES, Nuclear physics. B, 1995, pp. 799-801
Authors:
BLATTER M
FRANCIOLI P
Citation: M. Blatter et P. Francioli, ENDOCARDITIS PROPHYLAXIS - FROM EXPERIMENTAL-MODELS TO HUMAN RECOMMENDATION, European heart journal, 16, 1995, pp. 107-109
Authors:
HALPERIN SA
EASTWOOD B
BARRETO L
MILLS E
BLATTER M
REISINGER K
BADER G
KEYSERLING H
ROBERTS EA
GUASPARINI R
MEDD L
HUMPHREYS G
Citation: Sa. Halperin et al., SAFETY AND IMMUNOGENICITY OF 2 ACELLULAR PERTUSSIS VACCINES WITH DIFFERENT PERTUSSIS TOXOID AND FILAMENTOUS HEMAGGLUTININ CONTENT IN INFANTS 2-6 MONTHS OLD, Scandinavian journal of infectious diseases, 27(3), 1995, pp. 279-287
Authors:
WATSON B
ROTHSTEIN E
BERNSTEIN H
ARBETER A
ARVIN A
CHARTRAND S
CLEMENTS D
KUMAR ML
REISINGER K
BLATTER M
STARR SE
STAEHLE B
NGAI A
WHITE CJ
Citation: B. Watson et al., SAFETY AND CELLULAR AND HUMORAL IMMUNE-RESPONSES OF A BOOSTER DOSE OFVARICELLA VACCINE 6 YEARS AFTER PRIMARY IMMUNIZATION, The Journal of infectious diseases, 172(1), 1995, pp. 217-219
Authors:
ENTENZA JM
BLATTER M
GLAUSER MP
MOREILLON P
Citation: Jm. Entenza et al., PARENTERAL SPARFLOXACIN COMPARED WITH CEFTRIAXONE IN TREATMENT OF EXPERIMENTAL ENDOCARDITIS DUE TO PENICILLIN-SUSCEPTIBLE AND PENICILLIN-RESISTANT STREPTOCOCCI, Antimicrobial agents and chemotherapy, 38(12), 1994, pp. 2683-2688
Authors:
BERNSTEIN H
ROTHSTEIN E
PICHICHERO M
REISINGER K
BLATTER M
ARBETER A
BERNSTEIN D
SMITH J
LONG S
KRAUSE D
Citation: H. Bernstein et al., COMPARISON OF 3-COMPONENT ACELLULAR PERTUSSIS-VACCINE (DTAP) WITH WHOLE-CELL PERTUSSIS VACCINES (DTWP) AS A PRIMARY SERIES, Pediatric research, 35(4), 1994, pp. 10000174-10000174
Authors:
BLATTER M
FLUCKIGER U
ENTENZA J
GLAUSER MP
FRANCIOLI P
Citation: M. Blatter et al., SIMULATED HUMAN SERUM PROFILES OF ONE DAILY DOSE OF CEFTRIAXONE PLUS NETILMICIN IN TREATMENT OF EXPERIMENTAL STREPTOCOCCAL ENDOCARDITIS, Antimicrobial agents and chemotherapy, 37(9), 1993, pp. 1971-1976
Risultati:
1-11
|